Comparison

Xanthatin European Partner

Item no. TMO-T3S0153-50mg
Manufacturer TargetMol
CASRN 26791-73-1
Amount 50 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 99.29%
Citations Ginesta-Peris E , Garcia-Breijo F J , E. Primo-Yufera. Antimicrobial activity of xanthatin from Xanthium spinosum L.[J]. Letters in Applied Microbiology, 2010, 18(4):206-208.
Smiles [H][C@]12C[C@H](C)C(\C=C\C(C)=O)=CC[C@]1([H])C(=C)C(=O)O2
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 26791-73-1,Wnt/beta-catenin
Shipping Condition Cool pack
Available
Manufacturer - Targets
Apoptosis|||VEGFR|||Lipoxygenase|||Wnt/beta-catenin|||Antibacterial
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
246.3
Description
1. Xanthatin has cytotoxic activity. 2. Xanthatin has antibacterial and antifungal activies against MRSA. 3. Xanthatin may have therapeutic potential against NSCLC. 4. Xanthatin can inhibit murine melanoma B16-F1 cell proliferation possibly associated with activation of Wnt/β-catenin pathway and its activity against melanoma tumor might also be relevant to inhibition of angiogenesis.
Pathways
Angiogenesis|||Stem Cells|||Tyrosine Kinase/Adaptors|||Apoptosis|||Cytoskeletal Signaling|||Microbiology/Virology|||Metabolism

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close